FLORENCE, Italy — Exacerbations remain one of the major unresolved challenges in the management of chronic obstructive pulmonary disease (COPD), despite the introduction of new therapies. However, ...

AJMC®: What recent developments in the therapeutic landscape of chronic obstructive pulmonary disease (COPD) do you think have the greatest potential to shift how treatment is managed? Dr Martinez: ...

For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol, according to ...

The American Lung Association is announcing a new initiative to help people living with chronic obstructive pulmonary disease (COPD) better manage symptoms and improve quality of life. More than 16 ...

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that obstructs airflow and makes breathing difficult. It encompasses several respiratory conditions, including chronic ...

Add Yahoo as a preferred source to see more of our stories on Google. Dec. 10—(StatePoint) More than 11 million people in the United States are living with chronic obstructive pulmonary disease (COPD) ...

Add Yahoo as a preferred source to see more of our stories on Google. St. Vincent’s Riverside is now offering a breakthrough treatment for patients diagnosed with chronic pulmonary obstructive disease ...

Chronic obstructive pulmonary disease, or COPD, is a complex and progressive disease, and many patients continue to experience exacerbations, also known as flare-ups. For the past few decades, the ...

Daily voice recordings reveal early signs of asthma and COPD exacerbations, suggesting voice analysis could enhance remote ...

Recent research suggests that certain biologic medications called monoclonal antibodies may help treat emphysema more effectively than some current therapies. These medications include benralizumab ...